Gilberto de Castro Junior
Universidade de São Paulo
H-index: 49
Latin America-Brazil
Top articles of Gilberto de Castro Junior
Latin American Consensus on the Treatment of Head and Neck Cancer
2024/4
Gilberto De Castro Junior
H-Index: 33
Evandro Sobroza De Mello
H-Index: 20
David Conway
H-Index: 2
Paul Brennan
H-Index: 13
Final Analysis of the Phase 4 KEYNOTE-B10 Study: First-Line (1L) Pembrolizumab (pembro)+ Carboplatin (carbo)+ Paclitaxel (pacli) for Recurrent/Metastatic (R/M) Head and Neck …
International Journal of Radiation Oncology* Biology* Physics
2024/4/1
Systemic therapies for salivary gland carcinomas: An overview of published clinical trials
2024/3
Health Services Access Inequalities in Brazil Result in Poorer Outcomes for Stage III NSCLC—RELANCE/LACOG 0118
JTO clinical and research reports
2024/3/1
Canakinumab Versus Placebo in Combination With First-Line Pembrolizumab Plus Chemotherapy for Advanced Non–Small-Cell Lung Cancer: Results From the CANOPY-1 Trial
Journal of Clinical Oncology
2024/1/10
KontRASt-02: A Phase III Trial Investigating the Efficacy and Safety of the KRASG12C Inhibitor JDQ443 vs. Docetaxel in Patients with Previously Treated, Locally Advanced or …
International Journal of Radiation Oncology, Biology, Physics
2024/1/1
VP4-2023: Sotorasib 960 mg versus 240 mg in pretreated KRAS G12C advanced NSCLC
Annals of Oncology
2024/1/1
NEPTUNE: phase 3 study of first-line durvalumab plus tremelimumab in patients with metastatic NSCLC
Journal of Thoracic Oncology
2023/1/1
Câncer de pulmão
2023
Gilberto De Castro Junior
H-Index: 33
1361P Alectinib for treatment-naïve advanced ALK+ NSCLC selected via blood-based NGS: Updated analyses of outcomes, circulating tumour (ct) DNA and biomarker subgroups from …
Annals of Oncology
2023/10/1
Câncer de cabeça e pescoço
2023
Gilberto De Castro Junior
H-Index: 33
Does multidisciplinary team management improve clinical outcomes in Non-Small Cell Lung Cancer? A systematic review with meta-analysis
2023/9/22
EGFR Mutation Detection in Brazilian Patients With Non–Small-Cell Lung Cancer: Lessons From Real-World Data Scenario of Molecular Testing
JCO Global Oncology
2023/9
Survival inequalities in head and neck cancers: A hospital‐based cohort study
Head & Neck
2023/9
Gilberto De Castro Junior
H-Index: 33
Circulating metabolites and physical performance are predictors of overall survival in metastatic lung cancer patients
medRxiv
2023/8/24
A prospective cross-sectional study on the performance of the 2021 CKD-EPI equations without race in a multiracial population of adults with solid tumors in Brazil
American Journal of Kidney Diseases
2023/8/1
Time to Recurrence as a Prognostic Factor in Parathyroid Carcinoma
Journal of the Endocrine Society
2023/7
Gilberto De Castro Junior
H-Index: 33
Regina Matsunaga Martin
H-Index: 14
A phase II trial of JDQ443 in KRAS G12C-mutated NSCLC with PD-L1 expression <1% or PD-L1 expression ≥1% and an STK11 co-mutation.
2023/6/1
LATIFY: Phase 3 study of ceralasertib+ durvalumab vs docetaxel in patients with locally advanced or metastatic non-small-cell lung cancer that progressed on or after anti-PD-(L …
2023/6/1
Comparison of lung cancer clinical trials treatment options and standard practice in Brazilian national health system over the last decade.
2023/6/1
Co-Authors
